Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor
about
Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancerInterleukin-17 Could Promote Breast Cancer Progression at Several Stages of the DiseasePLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cellsLymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis.Pattern response of dendritic cells in the tumor microenvironment and breast cancerPromotion of lung tumor growth by interleukin-17C/EBPβ expression is an independent predictor of overall survival in breast cancer patients by MHCII/CD4-dependent mechanism of metastasis formation.Human papillomavirus infection correlates with inflammatory Stat3 signaling activity and IL-17 level in patients with colorectal cancer.Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells.Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer TherapyTumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients.High throughput screening of cytokines, chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery.Interleukin-17 and type 17 helper T cells in cancer management and research.Human papillomavirus infection correlates with inflammatory Stat3 signaling activity and IL-17 expression in patients with breast cancerIn vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.Interleukin-17: a promoter in colorectal cancer progressionHarnessing the immune system for the treatment of breast cancer.Th17 cells and Tregs: unlikely allies.MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potentialBreast cancer stem cells and the immune system: promotion, evasion and therapy.Role of IL-17 in Glioma ProgressionTh17 cytokines in non-melanoma skin cancer.Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer.The clinical and prognostic value of CXCL8 in cervical carcinoma patients: immunohistochemical analysis.Convergences and divergences of thymus- and peripherally derived regulatory T cells in cancerModulation of tumor immunity: a patent evaluation of WO2015026684A1.Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.The effect of foxp3-overexpressing Treg cells on non-small cell lung cancer cells.Initiative action of tumor-associated macrophage during tumor metastasis.Serum IL-17F combined with VEGF as potential diagnostic biomarkers for oral squamous cell carcinoma.Retinoic Acid Receptor-Related Orphan Receptors: Critical Roles in Tumorigenesis.Th17 cell-derived IL-17A promoted tumor progression via STAT3/NF-κB/Notch1 signaling in non-small cell lung cancer
P2860
Q26764743-D69D1DF5-06A8-48CB-B7A9-7FF647F8931BQ26771264-28A600C8-A333-48CA-A01B-F328608955A3Q33593900-F089A914-005E-44A8-9C04-F9C3E6D9A19AQ33776130-7772AF84-4B23-4CD6-AA16-5966FF7354F3Q34023724-1A10B302-3F02-49F2-89EC-5F8990D9ECAFQ34201267-C008A580-6301-4007-A9A7-40840C8AA6BFQ34657809-16C408DA-E52B-4193-856E-2FB970255D46Q35112546-06FA0613-9E98-49E2-A6CD-1EBDFEE3DCFFQ35551328-8B76ABC2-AD06-460B-856D-E61456084A54Q35826624-E90CB3C5-A452-4E3D-B08A-54933A32E12BQ36015463-D0533862-70CA-455E-93F1-3AA7F35DE2DCQ36198776-FDD8B689-23E0-4817-9EB4-EF0BFA616FD7Q36557288-58F6F8A0-9A8C-42DC-8410-E11FD6DECB8DQ37031654-E8E1D007-3352-4471-8C03-5270D61B9897Q37144134-06B25511-B5D3-4BB6-AA48-4326FD86CC4FQ37347391-466181A9-9BE8-49C6-93B6-DFF66C028D0BQ37376363-2EB8F902-F097-4F22-BF18-ADCDDEDD7052Q37409208-66405173-9670-4F60-AE60-24B14EEB85BAQ37476039-5C1E23D1-76BC-4A59-B776-41C7CADFE26DQ37700178-64DA6FDA-8274-418F-9EA7-E76FF8D18FAFQ37741582-EB7B2919-989D-4AB9-B50C-24660B5285ECQ38226597-85A21806-4248-4ADF-92BB-35795976F56EQ38270824-85AB178E-1811-4145-A177-0BFB10A7A697Q38912602-A84F5D6A-1063-4FAE-88FF-5C0B96874FBDQ38930857-85B5EBD8-8BFC-4CDA-9895-D312A208DFADQ42371161-82E61134-5FE8-4342-94C7-33906E99284EQ42571627-EE0865C1-F62C-4EFD-BC2D-4CB0A482A92EQ46640448-53BFACD7-EAC5-4932-B31F-EFAACE6F6C8CQ47109363-1133AC19-F6CD-49B5-90C5-9EB1762DE9E8Q50047665-4D37980D-3902-4333-B19B-25E1B3C5D7BBQ52694263-03D56191-ECFA-4CE3-B630-E2652BA86AB3Q53637767-B5CBEED9-2CE0-4482-87A3-CE0FA1D41799Q55401059-B50CBED3-83EE-459E-9ECC-DA4EEE61BF51Q58129687-57E89030-3CD6-4D58-9015-0A9F5071EB85
P2860
Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor
description
im Juni 2013 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 16 May 2013
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2013
@uk
name
Enrichment of regulatory T cel ...... and invasiveness of the tumor
@en
Enrichment of regulatory T cel ...... and invasiveness of the tumor
@nl
type
label
Enrichment of regulatory T cel ...... and invasiveness of the tumor
@en
Enrichment of regulatory T cel ...... and invasiveness of the tumor
@nl
prefLabel
Enrichment of regulatory T cel ...... and invasiveness of the tumor
@en
Enrichment of regulatory T cel ...... and invasiveness of the tumor
@nl
P2860
P50
P356
P1476
Enrichment of regulatory T cel ...... and invasiveness of the tumor
@en
P2093
Cristina R B Cardoso
Heitor R C Marana
P2860
P304
P356
10.1002/EJI.201242951
P407
P577
2013-05-16T00:00:00Z